Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease
© Crown copyright 2021..
BACKGROUND: The aim of this study was to examine the associations among depression, anxiety and health-related quality of life and predictors of improvement of quality of life in patients with inflammatory bowel disease.
METHODS: This was a prospective cohort study conducted in the gastroenterology clinic at McMaster University Medical Center in Hamilton, Ontario, Canada from May 2014 to March 2015. We included 60 adult patients above the age of 18 years old with a diagnosis of inflammatory bowel disease. We assessed anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) and Health Related Quality of Life (HRQoL) using the Short Inflammatory Bowel Disease questionnaire (SIBDQ) at baseline and after 6 months. Linear regression was performed to estimate the associations among depression, anxiety and predictors of improvement in health-related quality of life.
RESULTS: The anxiety scores decreased over the span of 6 months (median HADS-A baseline 9.00 [interquartile range {IQR} 6 to 12], and median HADS-A 6 months 7.00 [IQR 3.75 to 7.00]). There was a moderate negative correlation between anxiety (baseline r = -0.510, and 6-month r = -0.620; P < 0.001), depression (baseline r = -0.630, and 6-month r = -0.670; P < 0.001) and HRQoL scores. Using a multivariate linear regression model, elevated HADS score were associated with lower SIBDQ scores at baseline (Beta coefficient -0.696 [95% confidence interval {CI} -1.51 to -0.842]; P < 0.001). Lower SIBDQ score at baseline predicted decreased SIBDQ at 6 months (Beta coefficient 0.712 [95% CI 0.486 to 1.02]; P < 0.001).
CONCLUSION: Anxiety and depression are frequently seen in inflammatory bowel disease patients and lead to poor HRQoL. Psychological comorbidities may contribute to maladaptive behaviours and difficult disease management.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
Journal of the Canadian Association of Gastroenterology - 5(2022), 1 vom: 25. Feb., Seite 12-17 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Farbod, Yasamin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anxiety disorders |
|---|
| Anmerkungen: |
Date Revised 01.05.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/jcag/gwab008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM336508751 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM336508751 | ||
| 003 | DE-627 | ||
| 005 | 20231225232313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jcag/gwab008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1121.xml |
| 035 | |a (DE-627)NLM336508751 | ||
| 035 | |a (NLM)35118222 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Farbod, Yasamin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.05.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © Crown copyright 2021. | ||
| 520 | |a BACKGROUND: The aim of this study was to examine the associations among depression, anxiety and health-related quality of life and predictors of improvement of quality of life in patients with inflammatory bowel disease | ||
| 520 | |a METHODS: This was a prospective cohort study conducted in the gastroenterology clinic at McMaster University Medical Center in Hamilton, Ontario, Canada from May 2014 to March 2015. We included 60 adult patients above the age of 18 years old with a diagnosis of inflammatory bowel disease. We assessed anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) and Health Related Quality of Life (HRQoL) using the Short Inflammatory Bowel Disease questionnaire (SIBDQ) at baseline and after 6 months. Linear regression was performed to estimate the associations among depression, anxiety and predictors of improvement in health-related quality of life | ||
| 520 | |a RESULTS: The anxiety scores decreased over the span of 6 months (median HADS-A baseline 9.00 [interquartile range {IQR} 6 to 12], and median HADS-A 6 months 7.00 [IQR 3.75 to 7.00]). There was a moderate negative correlation between anxiety (baseline r = -0.510, and 6-month r = -0.620; P < 0.001), depression (baseline r = -0.630, and 6-month r = -0.670; P < 0.001) and HRQoL scores. Using a multivariate linear regression model, elevated HADS score were associated with lower SIBDQ scores at baseline (Beta coefficient -0.696 [95% confidence interval {CI} -1.51 to -0.842]; P < 0.001). Lower SIBDQ score at baseline predicted decreased SIBDQ at 6 months (Beta coefficient 0.712 [95% CI 0.486 to 1.02]; P < 0.001) | ||
| 520 | |a CONCLUSION: Anxiety and depression are frequently seen in inflammatory bowel disease patients and lead to poor HRQoL. Psychological comorbidities may contribute to maladaptive behaviours and difficult disease management | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anxiety disorders | |
| 650 | 4 | |a Depressive disorders | |
| 650 | 4 | |a Inflammatory bowel disease | |
| 650 | 4 | |a Quality of life | |
| 700 | 1 | |a Popov, Jelena |e verfasserin |4 aut | |
| 700 | 1 | |a Armstrong, David |e verfasserin |4 aut | |
| 700 | 1 | |a Halder, Smita |e verfasserin |4 aut | |
| 700 | 1 | |a Marshall, John K |e verfasserin |4 aut | |
| 700 | 1 | |a Tse, Frances |e verfasserin |4 aut | |
| 700 | 1 | |a Pinto-Sanchez, Maria Ines |e verfasserin |4 aut | |
| 700 | 1 | |a Moayyedi, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Chauhan, Usha |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the Canadian Association of Gastroenterology |d 2018 |g 5(2022), 1 vom: 25. Feb., Seite 12-17 |w (DE-627)NLM292841000 |x 2515-2092 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2022 |g number:1 |g day:25 |g month:02 |g pages:12-17 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jcag/gwab008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2022 |e 1 |b 25 |c 02 |h 12-17 | ||